Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids

Br J Dermatol. 2003 Mar;148(3):544-52. doi: 10.1046/j.1365-2133.2003.05174.x.

Abstract

Background: Keloids are characterized by abnormal proliferation of fibroblasts and overproduction of collagen. Insulin-like growth factor (IGF)-I is mitogenic for fibroblasts and a stimulatory factor for collagen synthesis.

Objectives: We have assessed the in vitro effects of quercetin on proliferation, collagen synthesis and the expression of the IGF system in keloid-derived fibroblasts.

Methods: Fibroblasts were isolated from earlobe keloids and exposed to quercetin at different concentrations. The inhibitory effects of quercetin on fibroblast proliferation were assayed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Western and Northern blot analyses.

Results: Quercetin inhibited keloid fibroblast (KF) proliferation in a dose-dependent manner. Significant growth inhibition was observed on day 2 of culture. The dose required for 50% growth inhibition was approximately 25 microg mL-1. Collagen 1 expression was significantly decreased while collagen 3 was almost undetectable following quercetin treatment. Basal levels of IGF-I receptor (IGF-IR) beta subunits, p85 subunit of phosphatidylinositol 3-kinase, c-Raf, phospho-Raf-1, phospho-MEK 1/2, phospho-mitogen-activated protein kinase, phospho-Elk-1 and phospho-Akt-1 were significantly reduced when KF cells were exposed to quercetin for 24 h. Blocking IGF-IR activity with IGF-IR antibody or neutralizing endogenous IGF-I activity with IGF-I antibody led to significant growth inhibition suggesting the role of IGF-I in regulation of KF proliferation.

Conclusions: Because the IGF system plays an important part in fibroblast cell proliferation and collagen production, the described activities of quercetin on the IGF system and collagen expression may provide a novel approach for the use of quercetin in treatment and/or prevention of hypertrophic scar and keloid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Northern / methods
  • Blotting, Western / methods
  • Cell Division / drug effects
  • Cells, Cultured
  • Collagen / biosynthesis
  • Dose-Response Relationship, Drug
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Humans
  • Insulin Receptor Substrate Proteins
  • Insulin-Like Growth Factor I / drug effects*
  • Insulin-Like Growth Factor I / metabolism
  • Keloid / drug therapy*
  • Keloid / metabolism
  • Keloid / prevention & control
  • Phosphoproteins / drug effects
  • Proto-Oncogene Proteins c-raf / analysis
  • Quercetin / therapeutic use*
  • Receptor, IGF Type 1 / drug effects*
  • Receptor, IGF Type 1 / metabolism
  • Receptors, Somatomedin / drug effects
  • Signal Transduction / drug effects

Substances

  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • Phosphoproteins
  • Receptors, Somatomedin
  • Insulin-Like Growth Factor I
  • Collagen
  • Quercetin
  • Receptor, IGF Type 1
  • Proto-Oncogene Proteins c-raf